A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01432353
Recruitment Status : Completed
First Posted : September 13, 2011
Last Update Posted : November 2, 2016
Information provided by (Responsible Party):
Genentech, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2014
  Study Completion Date : April 2014